JCI Cover 2012  Mucosal Immunology Cover 2012

Haake M, Haack B, Schäfer T, Harter PN, Mattavelli G, Eiring P, Vashist N, Wedekink F, Genssler S, Fischer B, Dahlhoff J, Mokthari F, Kuzkina A, Welters MJP, Benz TM, Sorger L, Thiemann V, Amanzar G, Selle M, Thein K, Späth J, Gonzalez MC, Reitinger C, Ipsen-Escobedo A, Wistuba-Hamprecht K, Eichler K, Filipski K, Zeiner PS, Beschorner R, Goedemans R, Gogolla FH, Hackl H, Rosswinkel RW, Thiem A, Romer Roche P, Joshi H, Pühringer D, Wöckel A, Diessner JE, Rüdiger M, Leo E, Cheng PF, Levesque PFP, Goebeler M, Sauer M, Nimmerjahn F, Schuberth-Wagner C, Von Felten S, Mittelbronn M, Mehling M, Beilhack A, van der Burg SH, Riedel A, Weide B, Dummer R, Wischhusen J. (2023). Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. Nature Communications 14(1):4253.

Daud M, Dasari P, Adelfinger M, Langenhorst D, Lother J, Slavkovic-Lukic D, Berges C, Kruhm M, Galler A, Schleussner C, Luther CH, Alberter K, Althammer A, Shaikh H, Pallmann N, Bodem J, El-Mowafy M, Beilhack A, Dittrich M, Topp MS, Zipfel PF, Beyersdorf N. (2023). Enolase 1 of Candida albicans binds human CD4+ T cells and modulates naïve and memory responses. Eur J Immunol e2250284 (doi: 10.1002/eji.202250284).

Nava Lauson CB, Tiberti S, Corsetto P, Conte F, Punit T, Machwirth M, Ebert S, Loffreda A, Scheller L, Mokhtari Z, Sheta D, Peters T, Raman AT, Greco F, Rizzo A, Beilhack A, Signori G, Tumino N, Vacca P, McDonnell L, Raimondi A, Greenberg PD, Huppa JB, Cardaci S, Caruana I, Rodighiero S, Nezi L, Manzo T. (2023). Linoleic acid potentiates CD8+ T cell metabolic fitness and anti-tumor immunity. Cell Metabolism 35(4):633-650.e9.

Solimando AG, Desantis V, Palumbo C, Marasco C, Pappagallo F, Montagnani M, Ingravallo G, Cicco S, Di Paola R, Tabares P, Beilhack A, Dammacco F, Ria R, Vacca A. (2023). STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure. Clin Exp Med, in press

Mueller JPJ, Dobosz M, O’Brien N, Abdoush N, Giusti AM, Lechmann M, Osl F, Wolf AK, Arellano-Viera E, Shaikh H, Sauer M, Rosenwald A, Herting F, Umana P, Colombetti S, Pöschinger T, Beilhack A. (2023). ROCKETS – a novel one-for-all toolbox for light sheet microscopy in drug discovery. Front Immunol 14:1034032.

Shaikh H, Pezoldt J, Mokhtari Z, Gamboa Vargas J, Le DD, Peña Mosca J, Arellano Viera E, Kern MAG, Graf C, Beyersdorf N, Lutz MB, Riedel A, Büttner-Herold M, Zernecke A, Einsele H, Saliba AE, Ludewig B, Huehn J, Beilhack A. (2022). Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells. JCI Insight 7(22):e154250.

Ataide MA*, Knöpper K*,  Cruz de Casas P*,  Ugur M, Eickhoff S, Zou M, Shaikh H, Trivedi A, Grafen A, Yang T, Prinz I, Ohlsen K, Gomez de Agüero M, Beilhack A, Huehn J, Gaya M, Saliba AE, Gasteiger G, Kastenmüller W. Lymphatic migration of unconventional T cells promotes site-specific immunity in distinct lymph nodes. Immunity, 55(10):1813-1828.e9.

Shaikh H, Beilhack A. (2022). GvHD: pDCs providing VIP protection. Blood 140(12):1333-1334.

Gamboa Vargas J*, Wagner J*, Shaikh H, Lang I, Medler J, Anany M, Steinfatt T, Peña Mosca J, Haack S, Dahlhoff J, Büttner-Herold M, Graf C, Arellano E, Einsele H, Wajant H*, Beilhack A. (2022). A TNFR2-specific TNF fusion protein with improved in vivo activity. Front Immunol 13:888274.

Ullrich E, Beilhack A, Wolf D. (2022). Editorial: Novel and Improved Methods for the Prevention and Treatment of Graft-Versus-Host Disease (GVHD). Front Immunol 13:966389.

Böckle D, Tabares P, Zhou X, Schimanski S, Steinhardt MJ, Bittrich M, Seebacher E, Ulbrich M, Wilnit A, Metz C, Heidemeier A, Bley T, Werner R, Buck A, Einsele H, Kortüm KM, Beilhack A*, Rasche  L*. (2022). MRD and imaging guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma. British Journal of Haematology 198(3):515-522.

Brandl A, Solimando AG, Mokhtari Z, Tabares P, Medler P, Manz H, Da Via M, Croci GA, Kurzwart M, Thusek S, Schneider T, Ebert R, Jakob F, Einsele H, Beilhack A. (2022). Junctional Adhesion Molecule-C expression specifies a CD138low/neg multiple myeloma cell population in mice and men. Blood Advances, 6(7):2195-2206

Gil-Pulido J*, Amézaga N*, Jorgacevic I*, Manthey HD, Rösch M, Brand T, Cidlinsky P, Schäfer S, Beilhack A, Saliba AE, Lorenz K, Prinz I, Waisman A, Korn T, Cochain C, Zernecke A. (2022). Interleukin-23 receptor expressing γδ T cells locally promote early atherosclerotic lesion formation and plaque necrosis in mice. Cardiovascular Research, 118(14):2932-2945.

Medler J, Kucka K, Melo V, Zhang T,  von Rotenhan S, Ulrich J, Bremer E, Hudecek M, Beilhack A, Wajant H. (2022). CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism. Theranostics 12(4):1486-1499.

Dahlhoff J, Manz H, Steinfatt T, Delgado-Tascon J, Seebacher E, Schneider T, Wilnit A, Mokhtari Z, Tabares P, Böckle D, Rasche L, Martin Kortüm K, Lutz MB, Einsele H, Brandl A, Beilhack A. (2022). Transient regulatory T cell targeting triggers immune control of multiple myeloma and prevents disease progression. Leukemia 36(3):790-800.

Shaikh H, Vargas JG, Mokhtari Z, Jarick KJ, Ulbrich M, Mosca JP, Viera EA, Graf C, Le DD, Heinze KG, Büttner-Herold M, Rosenwald A, Pezoldt J, Huehn J, Beilhack A. (2021). Mesenteric lymph node transplantation in mice to study immune responses of the gastrointestinal tract. Front Immunol 12:689896.

Majumder S, Jugovic I, Saul D, Bell L, Hundhausen N, Seal R, Beilhack A, Rosenwald A, Mougiakakos D, Berberich-Siebelt F. (2021). Rapid and efficient gene editing for direct transplantation of naive murine Cas9+ T cells. Front Immunol 12:683631.

Schwinn SMokhtari Z, Thusek S, Schneider T, Sirén AL, Tiemeyer N, Caruana I, Miele ESchlegel PG, Beilhack A*Wölfl M*. (2021). Cytotoxic effects and tolerability of gemcitabine and axitinib in a xenograft model for c-myc amplified medulloblastoma. Sci Rep, 11:14062

Solimando AG, Da Vià MC, Leone P, Borrelli P, Croci GA, Tabares P, Brandl A, Di Lernia G, Bianchi FP, Tafuri S, Steinbrunn T, Balduini A, Melaccio A, De Summa S, Argentiero A, Rauert-Wunderlich H, Frassanito MA, Ditonno P, Henke E, Klapper W, Ria R, Terragna C, Rasche L, Rosenwald A, Kortüm KM, Cavo M, Ribatti D, Racanelli V, Einsele H, Vacca A, Beilhack A. (2021). Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression. Haematologica 106(7):1943-1956.

Sueiro-Olivares M, Scott J, Gago S, Petrovic D, Kouroussis E, Zivanovic J, Yu Y, Strobel M, Cunha C, Thomson D, Fortune-Grant R, Thusek S, Bowyer P, Carvalho A, Beilhack A, Bignell E, Filipovic MR, Amich J. (2021). Fungal and host protein persulfidation are functionally correlated and govern fungal virulence and host antifungal potency. PLOS Biology 19(6):e3001247.

Horvat S, Yu Y, Manz H, Keller T, Beilhack A, Groll J, Albrecht K. (2021). Nanogels as antifungal-drug delivery system against Aspergillus fumigatus. Advanced NanoBiomed Research 1:2000060.

Zhang Y, Shen L, Dreissigacker K, Zhu H, Trinh-Minh T, Meng X, Tran-Manh C, Dees C, Matei AE, Chen CW, Ditschkowski M, Krauss S, Winkler J, Wolff D, Ziemer M, Beilhack A, Karrer S, Herr W, Mackensen A, Schett G, Spriewald BM, Distler JHW. (2021). Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease. Blood 137(17):2403-2416.

Yu Y, Wolf A, Thusek S, Heinekamp T, Bromley M, Krappmann S, Terpitz U, Voigt K, Brakhage AA, Beilhack A. (2021). Direct Visualization of Fungal Burden in Filamentous Fungus-Infected Silkworms. Journal of Fungi 7(2):136.

Bäuerlein CA, Qureischi M, Mokhtari Z, Tabares P, Brede C, Jordán Garrote AL, Riedel SS, Chopra M, Reu S, Mottok A, Arellano-Viera E, Graf C, Kurzwart M, Schmiedgen K, Einsele H, Wölfl M, Schlegel PG, Beilhack A. (2021). A T-cell Surface Marker Panel Predicts Murine Acute Graft-versus-Host Disease. Front Immunol 11:593321.

Xiao Y, Qureischi M, Dietz L, Vaeth M, Vallabhapurapu S, Klein-Hessling S, Klein M, Liang C, Koenig A, Serfling E, Mottok A, Bopp T, Rosenwald A, Buttmann M, Berberich I, Beilhack A, Berberich-Siebelt F. (2021). Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity. J Exp Med 218 (1): e20181853.

Röhner L, Ng YLD, Scheffold A, Lindner S, Köpff S, Brandl A, Beilhack A, Krönke J. (2021). Generation of a lenalidomide-sensitive syngeneic murine in vivo multiple myeloma model by expression of Crbn(I391V). Exp Hematol.  93:61-69.e4

Schneidereit D, Bröllichs A, Ritter, P, Kreiss L, Mokhtari Z, Beilhack A, Krönke G, Ackermann JA, Faas M, Grüneboom A, Schürmann S, Friedrich O. (2021). An advanced optical clearing protocol allows label-free detection of tissue necrosis via multiphoton microscopy in injured whole muscle. Theranostics, 11(6):2876-2891.

Eckert IN, Ribechini E, Jarick KJ, Strozniak S, Potter SJ, Beilhack A, Lutz MB. (2021). VLA-1 binding to collagen IV controls effector T cell suppression by myeloid-derived suppressor cells in the splenic red pulp. Front Immunol 11:616531.

Cordes S, Mokhtari Z, Bartosova M, Mertlitz S, Riesner K, Shi Y, Mengwasser J, Kalupa M, McGeary A, Schleifenbaum J, Schrezenmeier J, Bullinger L, Diaz-Ricart M, Palomo M, Carrreras E, Beutel G, Schmitt CP, Beilhack A, Penack O. (2021). Endothelial damage and dysfunction in acute graft-versus-host disease. Haematologica 106(8):2147-2160.

Horvat S, Vogel P, Kampf T, Brandl A, Alshamsan A, Alhadlaq HA, Ahamed M, Albrecht K, Behr VC, Beilhack A, Groll J. (2020). Crosslinked Coating Improves the Signal‐to‐Noise Ratio of Iron Oxide Nanoparticles in Magnetic Particle Imaging (MPI). ChemNanoMat 6(5): 755-758.

Rummler M, Ziouti F, Bouchard AL, Brandl A, Duda N, Bogen B, Beilhack A, Lynch ME, Jundt F*, Willie BM*. (2020). Mechanical loading prevents bone destruction and exerts anti-tumor effects in the MOPC315.BM.Luc model of myeloma bone disease. Acta Biomaterialia 119:247-258.

Nelke J, Medler J, Weisenberger D, Beilhack A, Wajant H. (2020). CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism. mAbs 12(1):1807721.

Horvat S, Yu Y, Böjte S, Teßmer I, Lowman DW, Ma Z, Williams DL, Beilhack A, Albrecht K, Groll J. (2020). Engineering nanogels for drug delivery to pathogenic fungi Aspergillus fumigatus by tuning polymer amphiphilicity. Biomacromolecules 21(8):3112-3121.

Yu Y, Albrecht K, Groll J, Beilhack A. (2020). Innovative therapies for invasive fungal infections in preclinical and clinical development. Expert Opinion On Investigational Drugs 29(9):961-971.

Abdulnasser Harfoush S, Hannig M, Le DD, Heck S, Leitner M, Omlor AJ, Tavernaro I, Kraegeloh A, Kautenburger R, Kickelbick G, Beilhack A, Bischoff M, Nguyen J, Sester M, Bals R, Dinh QT. (2020). High-dose Intranasal Application of Titanium Dioxide Nanoparticles Induces the Systemic Uptakes and Allergic Airway Inflammation in Asthmatic Mice. Respir Res. 21(1):168.

Ashour D, Arampatzi P, Pavlovic V, Förstner KU, Kaisho T, Beilhack A, Erhard F, Lutz MB. (2020). Th1 priming by vaccine dendritic cells depends on functional reprogramming of endogenous tolerogenic migratory XCR1+ dendritic cells towards IL-12 production. JCI Insight 5(10):e135143.

Brenner E, Schörg BF, Ahmetlić F, Wieder T, Hilke FJ, Simon N, Schroeder C, Demidov G, Riedel T, Fehrenbacher B, Schaller M, Forschner A, Eigentler T, Niessner H, Sinnberg T, Böhm KS, Hömberg N, Braumüller H, Dauch D, Zwirner S, Zender L, Sonanini D, Geishauser A, Bauer J, Eichner M, Jarick KJ, Beilhack A, Biskup S, Döcker D, Schadendorf D, Quintanilla-Martinez L, Pichler BJ, Kneilling M, Mocikat R, Röcken M. (2020). Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours. Nature Communications 11(1):1335.

Amich J*, Mokhtari Z*, Strobel M, Vialetto E, Sheta D, Yu Y, Hartweg J, Kalleda N, Jarick KJ, Brede C, Jordán-Garrote AL, Thusek S, Schmiedgen K, Arslan B, Pinnecker J, Thornton CR, Gunzer M, Krappmann S, Einsele H, Heinze KG, Beilhack A. (2020). 3D light sheet fluorescence microscopy of lungs to dissect local host immune – Aspergillus fumigatus interactions. mBio 11(1): e02752-19.

Wajant H*, Beilhack A*. (2019). Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer. Front Immunol 10: 2040.

Da Vià MC, Solimando AG, Garitano‐Trojaola A, Barrio S, Munawar U, Strifler S, Haertle L, Rhodes N, Teufel E, Vogt C, Lapa C, Beilhack A, Rasche L, Einsele H, Kortüm KM. (2019). CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement. The Oncologist 24:1-7.

Solimando AG,  Da Vià MC, Cicco S, Leone P, Di Lernia G, Giannico D, Desantis V, Frassanito MA, Morizio A, Delgado Tascon J, Ranieri G, Ria R, Rasche L, Kortüm KM, Beilhack A, Racanelli V, Vacca A*, Einsele H*. (2019). High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment. J Clin Med 8(7): 997.

Ribechini E, Eckert I, Beilhack A, Plessis N, Walzl G, Schleicher U, Ritter U, Lutz MB. (2019). Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability. JCI Insight 5(13):e128664.

Medler J, Nelke J, Weisenberger D, Steinfatt T, Rothaug M, Berr S, Hünig T, Beilhack A, Wajant H. (2019). TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity. Cell Death Dis 10(3):224.

Jarick KJ, Mokhtari Z, Scheller L, Hartweg J, Thusek S, Le DD, Ranecky M, Shaikh H, Qureischi M, Heinze KG, Beilhack A. (2018). Photoconversion of Alloreactive T Cells in Murine Peyer’s Patches During Acute Graft-Versus-Host Disease: Tracking the Homing Route of Highly Proliferative Cells In Vivo. Front Immunol 9:1468.

Hülsdünker J, Ottmüller KJ, Neeff HP, Koyama M, Gao Z, Thomas OS, Follo M, Al-Ahmad A, Prinz G, Duquesne S, Dierbach H, Kirschnek S, Lämmermann T, Blaser MJ, Fife BT, Blazar BR, Beilhack A, Hill GR, Häcker G, Zeiser R. (2018). Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset. Blood 131(16):1858-1869Commentary in: 

Ullrich E, Abendroth B, Rothamer J, Huber C, Büttner-Herold M, Kitowski V, Vogler T, Longerich T, Zundler S, Völkl S, Beilhack A, Rose-John S, Wirtz S, Weber GF, Ghimire S, Kreutz M, Holler E, Mackensen A, Neurath MF, Hildner K. (2018 ). BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease. J Clin Invest 128(3):916-930.

Wertheimer T, Velardi E, Tsai J, Cooper K, Xiao S, Kloss CC, Ottmüller KJ, Mokhtari Z, Brede C, deRoos P, Kinsella S, Palikuqi B, Ginsberg M, Young LF, Kreines F, Lieberman SR, Lazrak A, Guo P, Malard F, Smith OM, Shono Y, Jenq RR, Hanash AM, Nolan DJ, Butler JM, Beilhack A, Manley NR, Rafii S, Dudakov JA, van den Brink MRM. (2018). Production of BMP4 by endothelial cells is crucial for endogenous thymic regeneration. Sci Immunol 3:19.

Solimando AG, Brandl A, Mattenheimer K, Graf C, Ritz M, Ruckdeschel A, Stühmer T, Mokhtari Z, Rudelius M, Dotterweich J, Bittrich M, Desanti V, Ebert R, Trerotoli P, Frassanito MA, Rosenwald A, Vacca A, Einsele H, Jakob F, Beilhack A. (2018). JAM-A as a prognostic factor and new therapeutic target in multiple myeloma. Leukemia 32(3):736-743

Rudelius M, Rosenfeldt MT, Leich E, Rauert-Wunderlich H, Solimando AG, Beilhack A, Ott G, Rosenwald A. (2017). Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow micro-environment. Haematologica 103(1):116-125.

Klein-Hessling S, Muhammad K, Pusch T, Klein M, Rudolf R, Flöter J, Qureischi M, Beilhack A, Vaeth M, Kummerow C, Backes C, Schoppmeyer R, Hahn U, Hoth M, Bopp T, Berberich-Siebelt F, Patra A, Avots A, Müller N, Schulze A, Serfling E. (2017). NFATc1 controls the cytotoxicity of CD8+ T cells at multiple levels. Nature Communications 8:511.

Schuster S, Krüger T, Subota I, Thusek S, Rotureau B, Beilhack A, Engstler M. (2017). Developmental adaptations of trypanosome motility to the tsetse fly host environments unravel a multifaceted in vivo microswimmer system. Elife. 6: e27656.

Stegner D, Eeuwijk JMM, Angay O, Gorelashvili M, Pinnecker J, Schmitthausen P, Semeniak D, Friedrich M, Brede C, Beilhack A, Schulze H, Nieswandt B, Heinze KG. (2017). Thrombopoiesis is spatially regulated by the bone marrow vasculature. Nature Communications 8:127.

Ribechini E, Hutchinson JA, Hergovits S, Heuer M, Lucas J, Schleicher U, Jordán Garrote AL, Potter SJ, Riquelme P, Brackmann H, Müller N, Raifer H, Berberich I, Huber M, Beilhack A, Lohoff M, Bogdan C, Eyrich M, Hermanns H, Geissler EK, Lutz MB. (2017). Novel GM-CSF signals via IFNgR/IRF-1 and AKT/mTOR license monocytes. Blood Advances 1:947-960.

Müller E, Bauer S, Stühmer T, Mottok A, Scholz CJ, Steinbrunn T, Brünnert D, Brandl A, Schraud H, Kreßmann S, Beilhack A, Rosenwald A, Bargou RC, Chatterjee M. (2017). Pan-Raf co-operates with PI3K-dependent signalling and critically contributes to myeloma cell survival independently of mutated RAS. Leukemia 31:922-933.

Dagvadorj N, Deuretzbacher A, Weisenberger D, Baumeister E, Trebing J, Lang I, Köchel C, Kapp M, Kapp K, Beilhack A, Hünig T, Einsele H, Wajant H, Grigoleit GU. (2017). Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination. Cancer Immunol Immunother 66(3):319-332.

Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, Vaeth M, Kuen J, Holtappels R, Podlech J, Mottok A, Kraus S, Jordán Garrote AL, Bäuerlein CA, Brede C, Ribecchini E, Fick A, Seher A, Polz J, Ottmüller K, Baker J, Nishikii H, Ritz M, Mattenheimer K, Schwinn S, Winter T, Schäfer V, Krappmann S, Einsele H, Mueller TD, Reddehase MJ, Lutz MB, Männel DN, Berberich-Siebelt F, Wajant H, Beilhack A. (2016). Exogenous TNFR2 activation protects from acute GvHD by induction of host Treg expansion. J Exp Med 213:18811900.

Kalleda N, Amich J, Arslan B, Poreddy S, Mattenheimer K, Mokhtari Z, Einsele H, Brock M, Heinze KG and Beilhack A. (2016). Dynamic Immune Cell Recruitment After Murine Pulmonary Aspergillus fumigatus Infection under Different Immunosuppressive Regimens. Front Microbiol 7:1107.

Schulze M, Fedorchenko O, Sondergeld T, Knobbe-Thomsen C, Kraus S, Schwinn S, Beilhack A, Reifenberger G, Monoranu C, Siren AL, Jeanclos E, Gohla A. (2016). Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness. Oncogene 35(24):3163-77.

Dietl S, Schwinn S, Dietl S, Riedel S, Deinlein F, Rutkowski S, von Bueren AO, Krauss J, Schweitzer T, Vince GH, Picard D, Eyrich M, Rosenwald A, Ramaswamy V, Taylor MD, Remke M, Monoranu CM, Beilhack A, Schlegel PG, Wölfl M. (2016). MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties. BMC Cancer 16:115.

Dietl AM, Amich J, Leal S, Beckmann N, Binder U, Beilhack A, Pearlman E, Haas H. Histidine biosynthesis plays a crucial role in metal homeostasis and virulence of Aspergillus fumigatus. Virulence 7(4):465-76.

Amich J, Dümig M, O’Keeffe G, Binder J, Doyle S, Beilhack A, Krappmann S. (2016). Exploration of Sulfur Assimilation of Aspergillus fumigatus Reveals Biosynthesis of Sulfur-Containing Amino Acids as a Virulence Determinant. Infect Immun. 84(4):917-29. 

Dotterweich J, Tower RJ, Brandl A, Müller M, Hofbauer LC, Beilhack A, Ebert R, Glüer CC, Tiwari S, Schütze N, Jakob F. (2016). The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease. PLoS One. 11(5):e0155087.

Distler E, Albrecht J, Brunk A, Khan S, Schnürer E, Frey M, Mottok A, Jordán Garrote AL, Brede C, Beilhack A, Mades A, Tomsitz D, Theobald M, Herr W, Hartwig UF. (2016). Patient-individualized CD8+ cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient mice. Int J Cancer 138(5):1256-1268.

Chopra M, Langenhorst D, Beilhack A, Serfling E, Patra AK. (2015). Interleukin-2 critically regulates bone marrow erythropoiesis and prevents anemia development. Eur J Immunol 45(12): 3362-3374.

Kim BS, Nishikii H, Baker J, Pierini A, Schneidawind A, Pan Y, Beilhack A, Park CG, Negrin RS. (2015). Treatment with Agonistic DR3 Antibody Results in Expansion of Donor Tregs and Reduced Acute Graft-versus-Host Disease. Blood 126(4):546-557.

Chopra M, Brandl A, Siegmund D, Mottok A, Schäfer V, Biehl M, Kraus S, Bäuerlein CA, Ritz M, Mattenheimer K, Schwinn S, Seher A, Grabinger T, Einsele H, Rosenwald A, Brunner T, Beilhack A*, Wajant H*. (2015). Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GvHD. Blood 126(4):437-444. *Equal contribution and co-corresponding author.

Editorial: Blood 126(4):429-430.

Rieber N, Singh A, Carevic M, Öz H, Bouzani M, Amich J, Ost M, Ye Z, Ballbach M, Schäfer I, Mezger M, Klimosch SN, Weber ANR, Handgretinger R, Krappmann S, Liese J, Engeholm M, Schüle R, Salish HR, Marodi L, Speckmann C, Grimbacher B, Ruland J, Brown GD, Beilhack A, Loeffler J, Hartl D. (2015). Pathogenic fungi regulate T-cell immunity by inducing neutrophilic myeloid-derived suppressor cells through a Dectin-1/CARD9 and ROS-mediated mechanism. Cell Host Microbe 17(4): 507-14.

Ulges A, Klein M, Reuter S, Gerlitzki B, Hoffmann M, Grebe N, Staudt V, Stergiou N, Bohn T, Brühl TJ, Muth S, Yurugi H, Rajalingam K, Bellinghausen I, Tuettenberg A, Hahn S, Reißig S, Haben I, Zipp F, Waisman A, Probst HC, Beilhack A, Buchou T, Filhol-Cochet O, Boldyreff B, Breloer M, Jonuleit H, Schild H, Schmitt E, Bopp T. (2015). Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo. Nature Immunology 16(3): 267-275.

Meinhardt K, Kroeger I, Bauer R, Ganss F, Ovsiy I, Rothamer J, Büttner M, Atreya I, Waldner M, Bittrich M, Lehmann CHK, Rieger MA, Beilhack A, Zeiser R, Edinger M, Dudziak D, Mackensen A, Rehli M, Ullrich E. (2015). Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host- effects. Oncoimmunology 4:1, e981483.

Vaeth M, Bäuerlein CA, Pusch T, Findeis J, Chopra M, Mottok A, Rosenwald A., Beilhack A, Berberich-Siebelt F. (2015). Selective NFAT targeting in T cells ameliorates GvHD while maintaining anti-tumor activity. Proc Natl Acad Sci U S A 112(4): 1125-1130.

Chopra M, Kraus S, Schwinn S, Ritz M, Mattenheimer K, Mottok A, Rosenwald A, Einsele H, Beilhack A. (2013). Non-Invasive Bioluminescence Imaging to Monitor the Immunological Control of a Plasmablastic Lymphoma-Like B Cell Neoplasia after Hematopoietic Cell Transplantation. PLoS ONE 8(12): e81320.

Trebing J, Lang I, Chopra M, Salzmann S, Moshir M, Silence K, Riedel SS, Siegmund D, Beilhack A, Otto C, Wajant H (2014). A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivo. mAbs 7;6(1).

Thalheimer A, Korb D, Bönicke L, Wiegering A, Mühling B, Schneider M, Koch S, Riedel SS, Germer CT, Beilhack A, Brändlein S, Otto C. (2013) Non-invasive visualisation of tumour growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging. Journal of Surgical Research 185(1): 143-51.

Schliesser U, Chopra M, Beilhack A, Appelt C, Vogel S, Schumann J, Panov I, Vogt K, Schlickeiser S, Olek S, Wood K, Brandt C, Volk HD, Sawitzki B. (2013). Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β and RA treatment. European Journal of Immunology 43(12): 3291–3305.

Chopra M, Lang I, Salzmann S, Pachel C, Kraus S, Bäuerlein C, Brede C, Jordán Garrote AL, Mattenheimer K, Ritz M, Schwinn S, Graf C, Schäfer V, Frantz S, Einsele H, Wajant H, Beilhack A. (2013). Tumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1. PLoS ONE 8(9): e75737.

Wölfl M, Schwinn S, Yoo YE, Reß ML, Braun M, Chopra M, Schreiber SC, Ayala VI, Ohlen C, Eyrich M, Beilhack A, Schlegel PG. (2013). Src-kinase inhibitors sensitize human cells of myeloid origin to Toll-like-receptor-induced IL12 synthesis. Blood 122(7): 1203-1213.

Bäuerlein CA, Riedel SS, Baker J, Brede, C, Jordán Garrote AL, Ritz M, Schulz S, Grether M, Chopra M, Beilhack GF, Zeiser R, Schlegel PG, Einsele H, Negrin RS, Beilhack A. (2013). A diagnostic window for the treatment of acute GVHD prior to visible clinical symptoms in a murine model. BMC Medicine 11(1): 134.

Chopra M, Riedel SS, Biehl M, Donat S, von Krosigk V, Bäuerlein CA, Brede C, Jordan-Garrote AL, Schäfer V, Ritz M, Mattenheimer K, Degla A, Mottok A, Einsele H, Wajant H, Beilhack A. (2013). Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as player in TNF-induced experimental metastasis. Carcinogenesis 34(6): 1296-1303.

Heimberger T, Mindaugas A, Riedel S, Stühmer T, Schraud H, Beilhack A, Bumm T, Bogen B, Einsele H, Bargou R, Chatterjee M. (2013). The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma. British Journal of Haematology 160 (4): 465-476.

Brede C, Friedrich M, Jordán-Garrote AL, Riedel SS, Bäuerlein CA, Heinze K, Bopp T, Schulz S, Mottok A, Kiesel C, Mattenheimer K, Ritz M, von Krosigk V, Rosenwald A, Einsele H, Negrin RS, Harms GS, Beilhack A. (2012) Mapping immune processes in intact tissues at cellular resolution. Journal of Clinical Investigation 122 (12): 4439-4446.

Riedel SS, Mottok A, Brede C, Bäuerlein CA, Jordán Garrote AL, Ritz M, Mattenheimer K, Rosenwald A, Einsele, H, Bogen B, Beilhack A. (2012). Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma. PLoS ONE 7: e52398.

Ophir E, Or-Geva N, Gurevich I, Tal O, Eidelstein Y, Shezen E, Margalit R, Lask A, Shakhar G, Hagin D, Bachar-Lustig E, Reich-Zeliger S, Beilhack A, Negrin R, Reisner Y. (2013). Murine anti-3rd-party central-memory CD8+T-cells promote hematopoietic chimerism under mild conditioning: Lymph-node sequestration and deletion of anti-donor T-cells. Blood 121: 1220-1228.

Donat S, Hasenberg M, Schäfer T, Ohlsen K, Gunzer M, Einsele H, Löffler J, Beilhack A, Krappmann S. (2012). Surface display of Gaussia princeps luciferase allows sensitive fungal pathogen detection during cutaneous aspergillosis. Virulence 3(1): 50-61.

Wilhelm K, Ganesan J, Müller T, Dürr C, Grimm M, Beilhack A, Krempl C, Sorichter S, Gerlach UV, Jüttner E, Zerweck A, Gärtner F, Ferrari D, Kambham N, Fisch P, Finke J, Idzko M, Zeiser R (2010). Graft-versus-host disease enhanced by extracellular adenosine triphosphate activating P2X7R. Nature Medicine 16(12): 1434-1438.

Thorne SH, Liang W, Sampath P, Schmid T, Sikorski R, Beilhack A, Contag CH (2010). Targeting localized immune suppression with the tumor through repeat cycles of immune cell-oncolytic virus combination therapy. Molecular Therapy 18(9): 1698-1705.

Olson JA, Leveson-Gower DB, Gill S, Baker J, Beilhack A, Negrin RS (2010). NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects. Blood 115(21): 4293-4301.

Zangi L, Margalit R, Reich-Zeliger S, Bachar-Lustig E, Beilhack A, Negrin R, Reisner Y (2009). Direct Imaging of Immune Rejection and Memory Induction by Allogeneic Mesenchymal Stromal Cells (MSC). Stem Cells 27(11): 2865-2874.

Olson JA, Zeiser R, Beilhack A, Goldman JJ and Negrin RS (2009). Tissue specific homing and expansion of donor natural killer cells in allogeneic bone marrow transplantation. Journal of Immunology 183(5): 3219-3228.

Bjorck P, Beilhack A, Herman EI, Negrin RS, Engleman EG (2008). Plasmacytoid Dendritic Cells Take Up Opsonized Antigen Leading to CD4+ and CD8+ T Cell Activation In Vivo. Journal of Immunology 181(6): 3811-3817.

Nishimura R, Baker J, Beilhack A, Zeiser R, Olson JA, Karimi M, Negrin RS (2008). In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of anti-tumor activity. Blood 112(6): 2563-2574.

Beilhack A, Schulz S, Baker J, Beilhack GF, Nishimura R, Baker EM, Landan G, Herman EI, Butcher EC, Contag CH, Negrin RS (2008). Prevention of Acute Graft-versus-Host Disease by Blocking T-cell Entry to Secondary Lymphoid Organs. Blood 111(5): 2919-2928.

Editorial: Bacigalupo A (2008). Bad news for GVHD prevention. Blood 111 (5): 2499-2500.

Zeiser R, Leveson-Gower DB, Zambricki EA, Kambham N, Beilhack A, Loh J, Hou JZ, Negrin RS (2008). Differential impact of mTOR inhibition on CD4+CD25+Foxp3+ regulatory T cells as compared to conventional CD4+ T cells. Blood 111: 453-462.

Zeiser R, Zambricki EA, Leveson-Gower D, Kambham N, Beilhack A, Negrin RS (2007). Host-derived interleukin-18 differentially impacts regulatory an conventional T cell expansion during acute graft-versus-host disease. Biol Blood Marrow Transplant 13(12): 1427-1438.

Fernandez I, Zeiser R, Karsunky H, Kambham N, Beilhack A, Soderstrom K, Negrin RS, Engleman EG (2007). CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells. Journal of Immunology 179(5): 2808-2814.

Zeiser R, Nguyen V, Jing-Zhou H, Beilhack A, Zambricki E, Buess M, Contag CH, Negrin RS (2007). Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in the prevention of acute graft versus host disease. Blood 109(5): 2225-2233.

Nguyen VH, Zeiser R, daSilva DL, Chang DS, Beilhack A, Contag CH, Negrin RS (2007). In vivo dynamics of regulatory T cell trafficking and survival predict function in controlling GvHD following allogeneic transplantation. Blood 109(6): 2649-2656.

Cheung L, Han J, Beilhack A, Joshi S, Wilburn P, An A, Rockson SG (2006). An experimental model for the study of lymphedema and its response to therapeutic lymphangiognesis. BioDrugs. 20(6): 363-370.

Tabibiazar R, Cheung L, Swanson S, Han J, Beilhack A, An A, Wagner R, Rockson N, Shin WS, Rockson SG (2006). Inflammatory manifestations of experimental lymphatic insufficiency: functional, histopathological and molecular characterization. PLOS Medicine 3(7): e254.

Zeiser R, Nguyen V, Beilhack A, Schulz S, Buess M, Baker J, Contag CH, Negrin RS (2006). Inhibition of CD4+CD25+ regulatory T cell function by calcineurin dependent interleukin-2 production. Blood 108(1): 390-399.

Sato T, Habtezion A, Beilhack A, Schulz S, Butcher EC, Thorlacius H (2006). Short-term homing assay reveals a critical role for lymphocyte function associated antigen-1 in the hepatic recruitment of lymphocytes in graft-versus host disease. Journal of Hepatology 44(6): 1132-1140.

Cao YA, Bachmann MH, Beilhack A, Yang Y, Tanaka M, Swijnenburg RJ, Reeves R, Taylor-Edwards C, Schulz S, Doyle TC, Fathman CG, Robbins RC, Herzenberg LA, Negrin RS, Contag CH (2005). Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. Transplantation 80(1): 134-139.

International ADMO Award Andreas Beilhack & Stephan Schulz

Award Ceremony for the First International ADMO Award, Bologna, 2005

Beilhack A, Schulz S, Baker J, Beilhack GF, Wieland CB, Baker EM, Herman EI, Cao YA, Contag CH, Negrin RS (2005). In Vivo Analyses of Early Events in Acute Graft-versus-Host Disease Reveal Sequential Infiltration of T Cell Subsets. Blood 106(3): 1113-1122.

Editorial: Ferrara JLM (2005). GVHD: in vivo veritas. Blood 106(3): 772-773.

Cao YA, Wagers AJ, Beilhack A, Dusich J, Bachmann MH, Negrin RS, Weissman IL, Contag CH (2004). Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A 101: 221-226.